Optimization of antibodies for detection of the mismatch repair proteins MLH1, MSH2, MSH6, and PMS2 using a biotin-free visualization system

Applied Immunohistochemistry and Molecular Morphology

Volumn 14, Issue 1, 2006, Pages 115-121

  Hansen, Tine Plato ^a   Nielsen, Ole ^a   Fenger, Claus ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Antibody optimization; Colorectal carcinoma; Immunohistochemistry; Mismatch repair proteins

Indexed keywords

ANTIBODY; BIOTIN; MISMATCH REPAIR PROTEIN PMS2; POLYMER; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIGEN RETRIEVAL; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DILUTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCUBATION TIME; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; PRIORITY JOURNAL; PROTEIN ANALYSIS; STATISTICAL SIGNIFICANCE;

ADENOSINE TRIPHOSPHATASES; ANTIBODIES; BIOTIN; CARRIER PROTEINS; COLORECTAL NEOPLASMS; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS;

EID: 33645147875     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/01.pai.0000145183.75706.a2     Document Type: Article

References (30)

1. Ionov Y, Peinado MA, Malkhosyan S, et al. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature. 1993;363:558-561.
2. Aaltonen LA, Peltomaki P, Leach FS, et al. Clues to the parthogenesis of familial colorectal cancer. Science. 1993;260:812-816.
3. Cunningham JM, Christensen ER, Tester DJ, et al. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res. 1998;58:3455-3460.
4. Jass JR, Do KA, Simms LA, et al. Morphology of sporadic colorectal cancer with DNA replication errors. Gut. 1998;42:673-679.
5. Hemminki A, Mecklin JP, Jarvinen H, et al. Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy. Gastroenterology. 2000;119:921-928.
6. Elsaleh H, Joseph D, Grieu F, et al. Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer. Lancet. 2000;355:1745-1750.
7. de la CA. Microsatellite instability phenotype of tumors: genotyping or immunohistochemistry? The jury is still out. J Clin Oncol. 2002;20:897-899.
8. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998;58:5248-5257.
9. Jass JR, Biden KG, Cummings MC, et al. Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways. J Clin Pathol. 1999;52:455-460.
10. Bocker T, Schlegel J, Kullmann F, et al. Genomic instability in colorectal carcinomas: comparison of different evaluation methods and their biological significance. J Pathol. 1996;179:15-19.
11. Lindor NM, Burgart LJ, Leontovich O, et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol. 2002;20:1043-1048.
12. Dieumegard B, Grandjouan S, Sabourin JC, et al. Extensive molecular screening for hereditary non-polyposis colorectal cancer. Br J Cancer. 2000;82:871-880.
13. Cawkwell L, Gray S, Murgtroyd H, et al. Choice of management strategy for colorectal cancer based on a diagnostic immunohistochemical test for defective mismatch repair. Gut. 1999;45:409-415.
14. Debniak T, Kurzawski G, Gorski B, et al. Value of pedigree/clinical data, immunohistochemistry and microsatellite instability analyses in reducing the cost of determining hMLH1 and hMSH2 gene mutations in patients with colorectal cancer. Eur J Cancer. 2000;36:49-54.
15. Marcus VA, Madlensky L, Gryfe R, et al. Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. Am J Surg Pathol. 1999;23:1248-1255.
16. Terdiman JP, Gum JR Jr, Conrad PG, et al. Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing. Gastroenterology. 2001;120:21-30.
17. Sabattini E, Bisgaard K, Ascani S, et al. The EnVision + + system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques. J Clin Pathol. 1998;51:506-511.
18. Petrosyan K, Tamayo R, Joseph D. Sensitivity of a novel biotin-free detection reagent (Powervision+TM) for immunohistochemistry. J Histotechnology. 2002;25:247-250.
19. Plaschke J, Kruger S, Pistorius S, et al. Involvement of hMSH6 in the development of hereditary and sporadic colorectal cancer revealed by immunostaining is based on germline mutations, but rarely on somatic inactivation. Int J Cancer. 2002;97:643-648.
20. Shi SR, Key ME, Kalra KL. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem. 1991;39:741-748.
21. Rodriguez-Soto J, Warnke RA, Rouse RV. Endogenous avidin-binding activity in paraffin-embedded tissue revealed after microwave treatment. Appl Immunohistochem. 1997;5:59-62.
22. Bussolati G, Gugliotta P, Volante M, et al. Retrieved endogenous biotin: a novel marker and a potential pitfall in diagnostic immunohistochemistry. Histopathology. 1997;31:400-407.
23. Miller RT, Kubier P. Blocking of endogenous avidin-biotin activity in immunohistochemistry. The use of egg whites. Appl Immunohistochem. 1997;5:63-66.
24. Miller RT, Kubier P, Reynolds B, et al. Blocking of endogenous avidin-binding activity in immunohistochemistry. The use of skim milk as an economical and effective substitute for commercial biotin solutions. Appl Immunohistochem Mol Morphol. 1999;7:63-65.
25. Manavis J, Gilham P, Davies R, et al. The immunohistochemical detection of mismatch repair gene proteins (MLH1, MSH2, MSH6, and PMS2): practical aspects in antigen retrieval and biotin blocking protocols. Appl Immunohistochem Mol Morphol. 2003;11:73-77.
26. Shi SR, Guo J, Cote RJ, et al. Sensitivity and detection efficiency of a novel two-step detection system (PowerVision) for immunohistochemistry. Appl Immunohistochem Mol Morphol. 1999;7:201-208.
27. Young J, Simms LA, Biden KG, et al. Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis. Am J Pathol. 2001;159:2107-2116.
28. Halvarsson B, Lindblom A, Rambech E, et al. Microsatellite instability analysis and/or immunostaining for the diagnosis of hereditary non-polyposis colorectal cancer? Virchows Arch. 2004;444:1135-1141.
29. Rigau V, Sebbagh N, Olschwang S, et al. Microsatellite instability in colorectal carcinoma. The comparison of immunohistochemistry and molecular biology suggests a role for hMSH6 immunostaining. Arch Pathol Lab Med. 2003;127:694-700.
30. de Jong AE, va Puijenbroek M, Hendriks Y, et al. Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer. Clin Cancer Res. 2004;10:972-980.